At a glance
ClinicalIndex Comparison Record- ✓Histologically confirmed adenocarcinoma, squamous cell carcinoma, or adeno-squamous carcinoma of uterine cervix
- ✓FIGO stage IB (excluding IB3) or IIA1
- ✓Candidate for Type B or C radical hysterectomy
- ✓Adequate bone marrow, renal, and hepatic function
- ✕Histology other than adenocarcinoma, squamous cell carcinoma, or adeno-squamous carcinoma
- ✕Tumor size greater than 4 cm
- ✕FIGO stage II-IV except IIA1
- ✕Prior pelvic or abdominal radiotherapy
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Robot-assisted Approach to Cervical Cancer
In Brief
A clinical study evaluating Abdominal radical hysterectomy, Robot-assisted radical hysterectomy, and 1 other intervention for Cervical Cancer. Currently recruiting, targeting 800 participants across 1 site.
Detailed Summary
The purpose of the RACC trial is to compare the oncologic outcome defined as recurrence-free survival (RFS) between robot-assisted and open radical hysterectomy for the treatment of early stage cervical cancer.
Study Details
Timeline
Interventions
Radical hysterectomy (type B or C according to the Querleu\&Morrow classification) with pelvic lymphadenectomy
Radical hysterectomy (type B or C according to the Querleu\&Morrow classification) with pelvic lymphadenectomy
Assessment of sentinel lymph nodes using either radiotracer or indocyanine green (ICG)